Abstract Submission Deadline: 11 May, 2025

11th International Conference on Tularemia

Tularemia 2026, scheduled for 27-30 September at the Portofino Hotel & Marina in Redondo Beach, California, will focus on fundamental, clinical, and applied research regarding any aspect of Francisella tularensis. Research uncovers not only the biology of this fascinating bacterium, but also provides the basis for future development of treatments, preventive interventions, and disease diagnosis.

Tularemia 2026 Co-Chairs: Amy Rasley, PhD Deputy Group Leader, Microbiology/ Immunology, Lawrence Livermore National Laboratory, Livermore, USA and Nick Fischer, PhD, Staff Scientist, Lawrence Livermore National Laboratory, Livermore, USA

Scientific Organizing Committee

  • Joel Bozue, USAMRIID, USA, email
  • Roberto De Pascalis, Center for Biologics Evaluation and Research, FDA, USA, email
  • Nick Fischer, Lawrence Livermore National Laboratory, USA email (Co-Chair)
  • Carl Gelhaus, Appili Therapeutics, USA, email
  • Thomas Henry, INSERM, Lyon, France, email
  • Joseph Horzempa, West Liberty University, USA email 
  • Jason Huntley, Texas A&M College of Medicine USA, email
  • Tom Kawula, Washington State University, USA, email
  • Girish Kirimanjeswara, The Pennsylvania State University, USA, email
  • Karl Klose, University of Texas-San Antonio, USA, email
  • Max Maurin, University of Grenoble Alpes, France, email
  • Matt Meinig, USAMRIID, USA, email
  • Jeannine Petersen, Centers for Disease Control, USA, email
  • Amy Rasley, Lawrence Livermore National Laboratory, USA email (Co-Chair)
  • Lydia Roberts, Rocky Mountain Laboratories, NIAID, NIH; USA, email
  • Marina Šantić, University of Rijeka, Croatia, email
  • Anders Sjostedt, University of Umea, Sweden, email
  • Jiri Stulik, University of Defence, Czech Republic, email
  • Monique L van Hoek, George Mason University email

Working session and abstract submission topics:

  1. Clinical Outcomes, Diagnostics, and Treatment

    • Clinical outcomes, guidelines, and best practices

    • Novel therapies and diagnostics

    • New diagnostic methods for tularemia

    • Innovative approaches to tularemia treatment

    • Human infections, diagnosis, prophylaxis and treatment

  2. Pathogenesis, Virulence, and Host Interaction

    • Determinants of virulence and pathogenesis
    • Virulence factors
    • Pathogenesis, virulence and interactions with host cells
    • Host response to infection (including immunological mechanisms)
    • Host immunity
    • Animal models
    • Nutritional immunity
    • Metabolism (host and pathogen)
  3. Epidemiology, Ecology, and Reservoirs

    • Epidemiology and ecology
    • Epizootological studies in natural foci of tularemia
    • The association of tularemia with other natural focal infections
    • Persistence of F. tularensis in the environment
    • Environmental survival of Francisella tularensis
    • The impact of global warming on tularemia epizootics and range shifts of the pathogen, carriers, and transmitters
    • Evolution of tularemia endemic areas
  4. Taxonomy, Bacteriology, and Omics

  5. Vaccine Development and Immunological Correlates

    • Progress in vaccine development
    • Vaccine development
    • AI/ML to accelerate correlates of protection
  6. Research Funding and Outlook